SMIM10L1

gene
On this page

Summary

SMIM10L1 (small integral membrane protein 10 like 1, HGNC:49847) is a protein-coding gene on chromosome 12p13.2, encoding Small integral membrane protein 10-like protein 1 (P0DMW3).

Located in mitochondrion.

Source: NCBI Gene 100129361 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_001271592

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:49847
Approved symbolSMIM10L1
Namesmall integral membrane protein 10 like 1
Location12p13.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000256537
Ensembl biotypeprotein_coding
Entrez100129361

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000622602

RefSeq mRNA: 1 — MANE Select: NM_001271592 NM_001271592

CCDS: CCDS81667

Canonical transcript exons

ENST00000622602 — 1 exons

ExonStartEnd
ENSE000037382631117119411176016

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 87.86.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 57.0579 / max 341.8678, expressed in 1821 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
12419955.73101821
1242001.3269698

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
gastrocnemiusUBERON:000138887.86gold quality
muscle of legUBERON:000138387.26gold quality
right adrenal gland cortexUBERON:003582786.74gold quality
right adrenal glandUBERON:000123386.31gold quality
left adrenal glandUBERON:000123486.03gold quality
C1 segment of cervical spinal cordUBERON:000646985.93gold quality
substantia nigraUBERON:000203885.91gold quality
left adrenal gland cortexUBERON:003582585.17gold quality
heart left ventricleUBERON:000208485.00gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.84gold quality
Ammon’s hornUBERON:000195484.81gold quality
adrenal glandUBERON:000236984.77gold quality
putamenUBERON:000187484.56gold quality
amygdalaUBERON:000187684.43gold quality
hindlimb stylopod muscleUBERON:000425284.39gold quality
temporal lobeUBERON:000187184.33gold quality
hypothalamusUBERON:000189884.29gold quality
heartUBERON:000094883.89gold quality
nucleus accumbensUBERON:000188283.74gold quality
skeletal muscle tissueUBERON:000113483.64gold quality
right atrium auricular regionUBERON:000663183.06gold quality
anterior cingulate cortexUBERON:000983583.04gold quality
superior frontal gyrusUBERON:000266183.00gold quality
dorsolateral prefrontal cortexUBERON:000983482.98gold quality
cerebral cortexUBERON:000095682.92gold quality
caudate nucleusUBERON:000187382.65gold quality
prefrontal cortexUBERON:000045182.64gold quality
muscle tissueUBERON:000238582.45gold quality
frontal cortexUBERON:000187082.37gold quality
Brodmann (1909) area 9UBERON:001354082.26gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-CURD-112yes6.49
E-ANND-3no1.01

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

133 targeting SMIM10L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-8485100.0077.574731
HSA-MIR-3163100.0077.238605
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4425100.0067.591049
HSA-MIR-4673100.0066.641490
HSA-MIR-3924100.0072.092394
HSA-MIR-428299.9975.366408
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-569699.9872.364487
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-314899.9775.066478
HSA-MIR-365899.9673.874379
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-101-3P99.9475.032230
HSA-MIR-335-3P99.9373.364958
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-806399.9169.763146
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-627-3P99.9071.423316
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-990299.8969.152250

Literature-anchored findings (GeneRIF, showing 1)

  • Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells. (PMID:35290761)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosmim10l3ENSDARG00000100331
mus_musculusSmim10l1ENSMUSG00000072704
rattus_norvegicusSmim10l1ENSRNOG00000047309

Paralogs (4): SMIM10L2A (ENSG00000178947), SMIM10 (ENSG00000184785), SMIM10L2B (ENSG00000196972), SMIM10L3 (ENSG00000286075)

Protein

Protein identifiers

Small integral membrane protein 10-like protein 1P0DMW3 (reviewed: P0DMW3)

All UniProt accessions (1): P0DMW3

RefSeq proteins (1): NP_001258521* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029367SMIM10Family

Pfam: PF15118

UniProt features (2 total): chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0DMW3-F169.270.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 69 (showing top): GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, CADWELL_ATG16L1_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, TIEN_INTESTINE_PROBIOTICS_24HR_UP, MULLIGHAN_MLL_SIGNATURE_1_UP, TIEN_INTESTINE_PROBIOTICS_6HR_DN, SNF5_DN.V1_DN, ATF5_TARGET_GENES, NKX2_2_TARGET_GENES, SETD7_TARGET_GENES, ZNF22_TARGET_GENES, ZNF30_TARGET_GENES, ZNF33A_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

36 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SMIM10L1TNS2Q63HR2433
SMIM10L1TNS4Q8IZW8432
SMIM10L1TNS3Q68CZ2399
SMIM10L1TNS1Q9HBL0396
SMIM10L1SREBF1P36956192
SMIM10L1TRIT1Q9H3H1166
SMIM10L1DNPEPQ9ULA0161
SMIM10L1IWS1Q96ST2158
SMIM10L1TMEM254Q8TBM7154
SMIM10L1WDR31Q8NA23143
SMIM10L1RACK1P25388143
SMIM10L1PTENP60484120
SMIM10L1DCAF7P6196291
SMIM10L1UTP20O756910
SMIM10L1TOMM6Q96B490
SMIM10L1MUC15Q8N3870
SMIM10L1AOAHP280390

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A0D1DMK2, A0A1B0GUV1, A8MUN3, A9G6D9, B8DP12, L7N648, O90299, P03294, P06791, P0C5K6, P0C854, P0DMW3, P15099, P16791, P16835, P25620, P34245, P40057, P53211, P69616, P69617, P75410, Q04612, Q07649, Q08419, Q32L37, Q3BSH4, Q494R0, Q53513, Q5YCU7, Q5YCU8, Q64747, Q64902, Q6J1A5, Q6J8G1, Q6Q572, Q6REU5, Q6UXP9, Q6ZS49, Q6ZUT4

Diamond homologs: A0A0C4DGP1, P0DMW3, P0DMW4, P0DMW5, Q5U425, Q96HG1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

151 predictions. Top by Δscore:

VariantEffectΔscore
12:11171265:ACCGT:Adonor_gain0.9800
12:11171266:CCGTC:Cdonor_gain0.9800
12:11171547:TGCAG:Tdonor_loss0.9700
12:11171549:CAGGT:Cdonor_loss0.9700
12:11171550:AG:Adonor_loss0.9700
12:11171551:GG:Gdonor_loss0.9700
12:11171552:G:GCdonor_loss0.9700
12:11171553:T:Gdonor_loss0.9700
12:11171261:GCTT:Gdonor_loss0.9400
12:11171262:CTTA:Cdonor_loss0.9400
12:11171263:TTA:Tdonor_loss0.9400
12:11171264:TACC:Tdonor_loss0.9400
12:11171265:ACC:Adonor_loss0.9400
12:11171266:C:CGdonor_loss0.9400
12:11171269:T:TAdonor_gain0.9100
12:11171265:A:ACdonor_gain0.9000
12:11171266:C:CCdonor_gain0.9000
12:11171266:CCGT:Cdonor_gain0.8900
12:11171531:A:AGdonor_gain0.8200
12:11175885:TAAG:Tacceptor_gain0.8200
12:11171259:TTGC:Tdonor_loss0.7900
12:11171260:TGCT:Tdonor_loss0.7900
12:11171465:G:Adonor_gain0.7800
12:11172242:A:AGdonor_gain0.7800
12:11172243:G:GGdonor_gain0.7800
12:11172247:A:Gdonor_gain0.7800
12:11175886:AAGG:Aacceptor_gain0.7600
12:11171258:TTTGC:Tdonor_loss0.7500
12:11171413:GACAC:Gdonor_loss0.7300
12:11171414:ACAC:Adonor_loss0.7300

AlphaMissense

424 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:11171435:T:CF27L0.985
12:11171437:C:AF27L0.985
12:11171437:C:GF27L0.985
12:11171522:G:CG56R0.985
12:11171471:T:CF39L0.984
12:11171473:C:AF39L0.984
12:11171473:C:GF39L0.984
12:11171523:G:AG56D0.983
12:11171547:T:CL64S0.980
12:11171481:C:AA42D0.977
12:11171501:T:CF49L0.977
12:11171503:C:AF49L0.977
12:11171503:C:GF49L0.977
12:11171448:T:AL31H0.975
12:11171471:T:AF39I0.975
12:11171502:T:CF49S0.975
12:11171520:C:AA55E0.974
12:11171502:T:GF49C0.973
12:11171517:T:AV54D0.972
12:11171451:C:TS32F0.971
12:11171525:T:CS57P0.969
12:11171529:T:AV58E0.965
12:11171460:T:CL35P0.962
12:11171485:G:CW43C0.962
12:11171485:G:TW43C0.962
12:11171490:T:CL45P0.961
12:11171513:T:GY53D0.961
12:11171478:T:CL41P0.959
12:11171436:T:CF27S0.958
12:11171451:C:AS32Y0.958

dbSNP variants (sampled 300 via entrez): RS1000099420 (12:11173496 G>T), RS1000422884 (12:11170853 A>G), RS1000874378 (12:11169820 G>A), RS1001132920 (12:11174181 GACAAA>G), RS1001867940 (12:11175294 A>G), RS1002079424 (12:11170156 G>A,T), RS1002088914 (12:11173330 C>CA), RS1002299298 (12:11175509 G>A,C), RS1002538872 (12:11172507 A>G,T), RS1002981587 (12:11172801 C>T), RS1003220351 (12:11171010 T>C), RS1003947269 (12:11173896 C>T), RS1004244144 (12:11171516 G>A,C), RS1004306341 (12:11176465 G>A), RS1004617297 (12:11171289 G>A,C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
methylmercuric chlorideincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aaffects methylation1
sodium arseniteincreases expression1
Doxorubicindecreases expression1
Formaldehydedecreases expression1
Gold Compoundsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.